Lumen Bioscience awarded $16.2 million to advance C. difficile treatment
Lumen Bioscience has been granted $16.2 million by the U.S. Department of Defense to advance its C. difficile infection (CDI) treatment.
Source: biopharma-reporter.com
Page 4 - C Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from C Difficile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In C Difficile Today - Breaking & Trending Today
Calprotectin, Microbiota Levels Can Predict C Diff Recurrence, Study Finds
Age, fecal calprotectin level, toxin B polymerase chain reaction cycle threshold, immunosuppression, sex, and creatinine levels were identified as independent risk factors for developing recurrent Clostridioides difficile (C Diff) infection.
Source: ajmc.com
Asymptomatic C difficile Screening During ICU Admissions Reveals Greater Infection Risk
Clostridioides difficile (C difficile) screening in all ICU admissions identified asymptomatic carriers and their risk for developing and/or transmitting infection.
Source: ajmc.com
C difficile, COVID-19 Coinfection Risk Greatest in Older Women
Those with certain comorbidities, including peptic ulcer disease and renal failure, were at additional risk of developing Clostridioides difficile infection.
Source: ajmc.com
Hospital-Onset C Diff Not Linked to Cross-Transmission
Findings showed colonization with toxigenic C. difficile was associated with a greater risk of CDI during hospitalization than cross-transmission.
Source: hcplive.com